83 related articles for article (PubMed ID: 7858065)
1. Antiidiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo.
Soprana E; Vigo E; Verani A; Blom J; Siccardi AG; Vercelli D; Viale G
Lymphokine Cytokine Res; 1994 Oct; 13(5):325-30. PubMed ID: 7858065
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.
Boraschi D; Volpini G; Villa L; Nencioni L; Scapigliati G; Nucci D; Antoni G; Matteucci G; Cioli F; Tagliabue A
J Immunol; 1989 Jul; 143(1):131-4. PubMed ID: 2786529
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
4. Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo.
Faherty DA; Claudy V; Plocinski JM; Kaffka K; Kilian P; Thompson RC; Benjamin WR
J Immunol; 1992 Feb; 148(3):766-71. PubMed ID: 1530956
[TBL] [Abstract][Full Text] [Related]
5. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent human anti-IL-1RI antagonist antibodies.
Fredericks ZL; Forte C; Capuano IV; Zhou H; Vanden Bos T; Carter P
Protein Eng Des Sel; 2004 Jan; 17(1):95-106. PubMed ID: 14985542
[TBL] [Abstract][Full Text] [Related]
7. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFalpha, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein.
Matsukawa A; Yoshimura T; Fujiwara K; Maeda T; Ohkawara S; Yoshinaga M
Lab Invest; 1999 May; 79(5):591-600. PubMed ID: 10334570
[TBL] [Abstract][Full Text] [Related]
8. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
Gabay C; Porter B; Fantuzzi G; Arend WP
J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
[TBL] [Abstract][Full Text] [Related]
9. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
[TBL] [Abstract][Full Text] [Related]
10. IL-1 receptor accessory protein is an essential component of the IL-1 receptor.
Cullinan EB; Kwee L; Nunes P; Shuster DJ; Ju G; McIntyre KW; Chizzonite RA; Labow MA
J Immunol; 1998 Nov; 161(10):5614-20. PubMed ID: 9820540
[TBL] [Abstract][Full Text] [Related]
11. Mapping of biologically relevant sites on human IL-1 beta using monoclonal antibodies.
Massone A; Baldari C; Censini S; Bartalini M; Nucci D; Boraschi D; Telford JL
J Immunol; 1988 Jun; 140(11):3812-6. PubMed ID: 3259598
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
[TBL] [Abstract][Full Text] [Related]
13. Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance.
D'Ettorre C; De Chiara G; Casadei R; Boraschi D; Tagliabue A
Eur Cytokine Netw; 1997 Jun; 8(2):161-71. PubMed ID: 9262965
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.
Smith KA; Favata MF; Oroszlan S
J Immunol; 1983 Oct; 131(4):1808-15. PubMed ID: 6352804
[TBL] [Abstract][Full Text] [Related]
16. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
[TBL] [Abstract][Full Text] [Related]
18. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of IL-1 beta activities and receptor binding by monoclonal antibodies mapping within a discrete region of the protein.
Boraschi D; Villa L; Ghiara P; Presentini R; Bossù P; Censini S; Nucci D; Massone A; Rossi R; Flad HD
Lymphokine Cytokine Res; 1991 Oct; 10(5):377-84. PubMed ID: 1722713
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon DY; Dinarello CA
J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
